How Sick Care Drains Your Health and What To Do About It

Almost everyone agrees the American medical system is broken. The examples are endless: staggering costs, mind-numbing bureaucracy, and poor outcomes. Yet, few agree on how to fix it. All participants, including the government, remain frozen by conflicting internal incentives and constraints preventing meaningful reform.

This article takes a different approach called 'Radical Acceptance.' This is not the acceptance of futility, but the clarity of seeing the system for what it actually is: a 'Sick Care System.'  While policymakers and academics focus on fixing the 'supply side' (the medical system), they often assume the consumer remains a passive participant. We make a different assumption: the medical system is unlikely to change any time soon. Therefore, the consumer's best bet is to become smarter about how they navigate this unsatisfying equilibrium.

This article provides the 'Rational Armor' you need to extract value from the dysfunction and protect both your health and your wealth.

About the author:  Jeff Hulett leads Personal Finance Reimagined, a decision-making and financial education organization. He teaches personal finance at James Madison University and provides entrepreneurial services. Check out his book -- Making Choices, Making Money: Your Guide to Making Confident Financial Decisions.

Jeff is a career banker, data scientist, behavioral economist, and choice architect. Jeff has held banking and consulting leadership roles at Wells Fargo, Citibank, KPMG, and IBM.

Words Matter

The challenge of navigating the medical industrial complex is not a lack of well-intentioned people; most medical personnel truly care and want the best for their patients. However, a profound disconnect exists between these individual intentions and the business system's actual mechanical functioning. "Health care" is an intention-based marketing slogan, while the reality is a Sick Care system optimized for employer-benefiting transactions and billable procedural events. Words matter: the sooner you pivot your thinking to this reality, the sooner you can reclaim a healthier life.

This distinction matters because, as discussed later, providers function as high-sensitivity machines calibrated to detect billable opportunities rather than manage wellness. Consequently, the individual becomes a secondary component in a factory assembly line focused on billing cycles. Long-term well-being frequently surrenders to the efficiency of the machine.

The Psychology of the Trap: Loss Aversion

To understand why the Billing Machine is so successful, we must look at Prospect Theory. As Daniel Kahneman and his collaborator Amos Tversky demonstrated, humans do not perceive value linearly; we are hard-wired for Loss Aversion. We feel the pain of a loss roughly twice as intensely as the joy of an equivalent gain.

In the "Sick Care" context, this coefficient is even higher. [USC Schaeffer and NBER] Loss aversion is an evolutionary signal helping drive our species' success. However, we have a choice in how we interpret the signal, and our emotional default benefits from a Bayesian decision process. When a provider frames a recommendation as "preventing a loss of health," our rational mind short-circuits. We become price-insensitive and biologically challenged to shop for value. This psychological vulnerability is the engine of the Referral Trap: even as costs skyrocket, the "fear of loss" ensures the machine operates without the price discipline found in a functional market.

Most people wish to live long, healthy lives. This objective focuses on healthspan, representing the period spent in good health rather than merely total years lived. Protecting healthspan requires an upgraded relationship with the Sick Care system through a Bayesian perspective. This framework moves the patient from a passive unit of billing to an active Decision Advocate. This decision framework enables a more accurate and healthy relationship with potential losses. By viewing Sick Care as a tool to use only when necessary, a person regains control over their own health care.

1. The Myth of the "Insurance Villain"

It is human nature to categorize agents of a system as "good guys" or "bad guys." This is a mistake. Agents of a system act according to their incentives and constraints. It is ultimately the system itself and how you engage that system, creating good or bad outcomes for you. Notably, a common theme suggests insurance companies are the "bad guys" in the Sick Care system.

However, the Sick Care system agents prioritize short-term procedural events and symptom management over the complex pursuit of long-term health.

While insurers and doctors argue over the price of a procedure, they both rely upon the same high-sensitivity machine to generate revenue. The insurer requires a standardized Standard Operating Procedure (SOP) to maintain administrative order and predictability. The medical provider utilizes the Standard of Care (SOC) to justify those same billable actions. This "standards" rivalry ensures both entities capture the revenue pie while the patient pays the bill. The problem is not a single "bad" actor; it is a shared incentive structure prioritizing the billing cycle over the preservation of health.

Sick Care System Agent Overview

2. The Standard Of Care as a Shield and a Sales Pitch

Modern medical practitioners frequently face a conflict between their Hippocratic Oath and the business metrics of a hospital network. The Standard of Care (SOC) helps resolve this tension.

The SOC serves two primary purposes. First, it provides plausible deniability. If an unnecessary procedure leads to a complication, the physician hides behind the company manual. Adherence to protocol insulates the practitioner from malpractice claims. The doctor appears compliant rather than aggressive.

Second, the SOC functions as an effective marketing tool. When a patient expresses skepticism regarding an expensive or invasive test, the physician bypasses individual reasoning. They frame the decision as an objective necessity. They might say: "It is just our standard protocol," or "This represents the system-wide Standard of Care for your symptoms." This appeal to authority removes the burden of personal justification. It creates an illusion of certainty. This environment discourages the patient from asking deeper questions about personal risk.

The SOC acts as the legal and clinical justification for a broader array of financial drivers. Please see the appendix at the end of this article for a comprehensive table describing the full set of incentives and the downstream revenue cascades benefiting the entire referral network.

3. The Statistical Battlefield: Sensitivity versus Specificity

In Signal Detection Theory, every test possesses two primary traits: sensitivity and specificity. In a world of imperfect information and an uncertain future, medical tests are not perfect. There are tradeoffs between how well medical challenges are identified (positives) or eliminated (negatives).

• Sensitivity represents the ability to identify a true positive. A highly sensitive test functions like a nervous smoke alarm. It triggers if a person lights a candle. By lowering that threshold, you capture every real case (true positives), but you inevitably capture innocent false positives as well. Medical Example: An MRI scan for minor back pain often possesses high sensitivity. It frequently identifies common, age-related disc bulges as "abnormalities" even when those findings do not cause the patient's symptoms.

• Specificity represents the ability to identify a true negative. A highly specific test functions like a skeptical guard. It barks only when it possesses absolute certainty of an intruder. In a high-specificity environment, the "skeptical guard" is so worried about barking at a neighbor that he might stay quiet while a thief slips past. This results in a false negative. Medical Example: A biopsy serves as a highly specific diagnostic tool. The pathologist identifies the presence of unique malignant cells to ensure the physician does not perform surgery on a patient with a benign growth.

In the Sick Care landscape, physicians possess sensitivity incentives which function similarly to a sales commission. The system relies upon procedure-based billing, often measured through Relative Value Units (RVUs). This metric ensures the physician receives a financial reward for a false positive. For example, a practitioner may categorize a harmless skin blemish as "potential cancer" to justify a biopsy. Each additional procedure increases the RVU total and, consequently, the physician’s year-end bonus.

Conversely, the system punishes a false negative. Missing a diagnosis could lead to financial and legal consequences. This environment creates a false positive machine. When rewards favor "doing something" and punishments result from "missing something," the physician tunes the internal alarm to its highest sensitivity. This results in a flood of unnecessary tests. The system labels these as preventative care. In reality, they represent a strategy to maximize billing opportunities through a commission-style payout.

Medical Testing Incentives & The Statistical Battleground

High False Positive Rate

Via High Sensitivity

The Moral Neutrality of the Machine

The Sick Care system is neither good nor bad; it is simply a mechanism which reliably responds to incentives and constraints. Because biological conditions are inherently uncertain, medical personnel must assess probabilities based on their prediction of sensitivities and specificities. These statistical models suggest a range of possible outcomes. When a "gray area" requiring clinical judgment emerges, the internal logic of the system pushes the decision toward whichever outcome maximizes profitability while adhering to a Standard of Care.

The physician is not a villain for following these incentives, any more than a smoke alarm is "wrong" for being hypersensitive to a candle flame. Both perform exactly as calibrated. However, the patient must recognize this calibration is not necessarily tuned for the individual's long-term healthspan. While the system seeks to maximize the billable event, your job as a consumer is to intervene in the gray area. You must make choices returning long-term healthy outcomes, effectively recalibrating the machine’s judgment to serve your own life rather than the system's ledger.

Redefining "Good Insurance" as a Tool for Stewardship

A prevailing misunderstanding exists regarding the nature of "good insurance." A common myth suggests high-quality coverage provides on-demand, low-deductible access to highly-rated medical personnel. The reality of the Sick Care system requires the medical consumer to think differently. Good insurance motivates a person to become a steward of their own long-term health. Superior coverage provides "skin in the game," encouraging the practice of sound health decisions and fostering great discernment for how and when to engage the Sick Care system. Notably, insurance promoting this level of autonomy often carries lower premiums than its mythical counterpart.

Section 7 and the Appendix provide specific suggestions for becoming a superior consumer of the Sick Care system. The most critical step is practicing these strategies in advance of any clinical engagement. When health is compromised, thinking clearly becomes difficult. The system will suggest decisions optimized for its own ledger, not your longevity. If your decision-making approach is practiced, then the habit is more likely to engage accurately on your behalf. Treating these Bayesian tools as a practiced routine ensures you maintain agency even when the "high-sensitivity machine" attempts to overwhelm your judgment.

4. The Great Revenue War: Doctors versus Insurers

This sensitivity represents a primary weapon in an economic war between the interests of doctors and the interests of insurers.

On one side, medical providers across the value chain maximize revenue by increasing the volume of billable procedures through errors of commission. Whether driven by hospital-mandated productivity metrics or defensive medicine, these practitioners take procedural actions which are more likely to lack medical necessity.

On the other side, insurance companies attempt to protect profit margins by limiting payments. However, they remain trapped in the SOP paradox. To manage thousands of providers, insurers create rigid checklists. They inform the doctor: "If the test result is X, we will pay for procedure Y." This creates a slam dunk for the medical practice. The physician knows which buttons to push to ensure payment. The doctor secures revenue. The insurer gains administrative ease. The patient remains the collateral damage of this economic battle.

5. The Illusion of Progress: Lifespan versus Healthspan

Medical professionals frequently defend the current system by citing improvements in lifespan. They point to survival rates for acute events and long-term management of neurodegenerative diseases. However, a skeptic distinguishes between lifespan (the number of years lived) and healthspan (the quality of years lived).

Evidence suggests health outcomes are declining when measured by the value of health produced relative to the capital invested. The system has become excellent at preventing immediate death while failing to improve the quality of life. Patients often spend more money to exist in a state of managed illness. We observe a "revolving door" effect where the machine manages symptoms through procedural steps without resolving the underlying pathology. If the system produced actual health, the prevalence of chronic conditions would decrease. Instead, morbidity remains at historic highs despite record-breaking expenditure. This synthesis confirms the origin of the Sick Care system. The American medical-industrial complex has not failed; it has evolved into a system optimized for procedural volume rather than restorative health. The inherent focus on high-sensitivity testing and billable events ensures the creation of "repeat customers." Consequently, what many describe as "healthcare" is more accurately viewed as a symptom-management machine designed to maintain an unsatisfying equilibrium.

6. Patient Vigilance: The "Skin in the Game" Incentive

In this landscape, the patient remains the only actor whose incentives align with actual health outcomes. Historically, low deductibles shielded patients from the true cost of the high-sensitivity machine. When a third party pays, patients frequently fail to question the SOC.

This dynamic is changing. High-deductible plans introduce skin in the game for the patient. Patient vigilance has become an economic necessity. When a standard protocol costs the patient thousands of dollars out of pocket, the incentive for vigilance increases.

However, financial exposure alone is rarely enough to change behavior. Research suggests that even with high deductibles, many patients remain price-insensitive and continue to rely blindly on the doctor's referral network. This inertia often stems from a fear of the unknown and the administrative friction of seeking outside alternatives.

Skin in the game provides the motive for change, but the Bayesian approach serves as the necessary bridge to becoming a better consumer. By using a probability-based framework, the patient gains the confidence to step outside the referral network. This financial and intellectual stake transforms the patient from a passive consumer into an active skeptic. When the patient pays the bill, they often demand higher specificity. They utilize Bayesian logic to ask if the procedure provides real value or merely serves as a billing convenience for the provider.

The Veil of "Cost Blindness"

A core mechanism of the Sick Care system is the intentional blindness regarding patient costs. Research in health economics suggests most physicians operate in a state of clinical insulation; they are trained to seek "more data" while remaining unaware of the specific financial burden a test places on the individual. This default condition serves the system’s incentives perfectly. It allows the provider to maintain "plausible deniability" while acting as a high-sensitivity agent, ordering tests of spurious value under the guise of thoroughness.

Evidence from behavioral studies indicates this "sensitivity machine" is highly reactive to the source of payment. When physicians believe a third party covers all costs, they exhibit Provider-Induced Demand, a phenomenon where the supply of medical services creates its own demand regardless of patient need. However, when the "veil" is pierced by a patient sharing the reality of a high-deductible plan, the clinical logic shifts.

Evidence from the Journal of the American Board of Family Medicine suggests while doctors rarely initiate cost-conversations, they are significantly more likely to modify treatment plans when patients do. When a patient communicates financial "skin in the game," physicians move from a default of "everything possible" to a Bayesian evaluation of "what is probable." This transition to discerning judgment helps calibrate the machine for specificity, effectively halting the expensive cascades often triggered by a false positive. By speaking up, you force the system to acknowledge the "Financial Toxicity" of its protocols, compelling a move toward higher-value care.

7. The Bayesian Solution: Becoming a Decision Advocate

The wise patient recognizes the system has traded nuanced judgment for revenue-producing Standard of Care protocols. Navigating this environment requires a Bayesian structured decision process. Bayesian Inference is a wonderful, time-tested method for making high-stakes decisions under uncertainty. While the underlying probabilistic math is powerful, many people lose the intuition by getting bogged down in the formulas. The following suggestions offer a compromise: they are Bayesian-inspired tools which provide the incredible power of the logic without the burden of the math. This framework moves the patient away from binary certainty toward a calculated probability of being correct.

In our experience with students and clients, the accuracy of the Bayesian intuition buys you more than the precision of the Bayesian probabilistic math.

• Change the Action Default: When it comes to our health, our default tends to be action-oriented, especially if discomfort is involved. However, so often the best prescription for a medical situation is waiting and letting our bodies heal or speak. In a system tuned for high sensitivity, the "Action Default" may be a trap leading to the Billing Machine cascade. [Bayesian formula relationship: Prior]

• Invest in Healthy Behavior: You want to avoid the Sick Care system for the right reason, because it is not necessary. Eating well and exercising may sound trite, but it is literally the answer to a long health span. [Bayesian formula relationship: Prior]

• Seek to Understand the Incentives: Initiate an honest discussion with your medical provider regarding their financial motivations. Ask how much the practice earns on a specific procedure recommendation. Inquire about the referral network and how those referrals impact the provider's income. A transparent understanding of the "commission" structure allows you to adjust your confidence in the recommendation. [Bayesian formula relationship: Likelihood]

• Seek Incentive-Neutral Evidence: Obtain a second opinion from an expert who does not profit from the procedure. A retired specialist often provides a clean diagnosis. In the proper context, a trusted social media professional content creator can help. [Bayesian formula relationship: Likelihood]

• Evaluate the Base Rate: Ask about the probability of healing without intervention over thirty days. The prior probability of a body healing itself frequently exceeds the suggestions of an SOC. [Bayesian formula relationship: Baseline Evidence]

• Analyze Option Asymmetry: Favor the reversible path. A patient retains the option for surgery later. One cannot undo an incision once it occurs. [Bayesian formula relationship: Posterior]

• Focus on Healthspan: Prioritize decisions enhancing the quality of life rather than those simply extending the billing cycle of a chronic condition. [Bayesian formula relationship: Posterior]

• Practice "De-Moral Hazarding": Intentional exposure to small losses is a catalyst for attention and intentionality. For example, treat the high deductible like the irritant in an oyster, eventually producing a pearl. Let financial friction help you develop the pearl of wisdom. Your personal vigilance serves as the best defense against errors of commission (unnecessary care). [Bayesian formula relationship: Baseline Evidence]

• Avoid Employer-Tied Incentives: The basis for our incentive challenge traces back to employer-funded Sick Care. Employers prioritize immediate labor productivity and require you back on the job ASAP. Consequently, they provide Sick Care "benefits" optimized for quick-fix interventions rather than long-term healthspan. While ACA-based plans or private options often appear more expensive, they provide a refreshing opportunity to decouple your medical decisions from your employer's productivity requirements. [Bayesian formula relationship: Likelihood] Please refer to Appendix: The Decision Advocate’s Toolkit for specific strategies on how to restructure your insurance and provider relationships to achieve this autonomy.

For a deeper dive into Bayesian Inference, including the math and our Bayesian tool, please see: Embrace the Power of Changing Your Mind: Think Like a Bayesian to Make Better Decisions

8. The Future: Narrowing the Fog of Ambiguity

While the current system relies on "statistical fog" to generate revenue, technology is shifting the landscape. Genomics and artificial intelligence improve the precision of medical data. As these technologies advance, the bell curves of signal and noise grow thinner and taller. In other words, science and technology ultimately produce more accurate and precise medical tests.

This narrowing of the overlap shrinks the space where false positives and the financial incentives attached to them currently reside.  (Please see the next image) As the "Machine" loses its ability to hide revenue-seeking behavior behind ambiguity, the role of the patient as a Decision Advocate becomes even more powerful. Technology provides the data, but the patient must still provide the Bayesian logic to apply it.

The Power Of Science & Technology

How ongoing improvements change medical incentives --

The noise and signal distributions become narrower and taller

Science and Technology reduce false positive incentive space

9. Conclusion: Radical Acceptance as the Path to Power

Radical Acceptance is the ultimate tool for personal sovereignty. Accepting the inherent nature of the American Sick Care system—rather than fighting against its obvious dysfunction—allows for superior decision-making. Anger toward a physician for following structural incentives yields no value. Instead, recognizing those incentives as fixed variables allows a person to adjust their posterior beliefs and navigate the exam room with clarity.

The American Sick Care system performs exactly as its design dictates. It is a high-sensitivity machine optimized to maximize capture and revenue. However, once you understand the statistical errors of commission and the "revolving door" of managed illness, you cease to be a mere unit of billing. By embracing the friction of "skin in the game" and applying a Bayesian filter to every recommendation, you exit the role of passive consumer. You become the Chief Decision Officer of your own life, extracting precisely what you need from a Sick Care system while protecting the long-term integrity of your healthspan.

Appendix: Strategic Insight for the Decision Advocate

As the table demonstrates, the Standard of Care is not merely a clinical guideline; it is an economic lubricant. Each agent within the referral network benefits from the high-sensitivity threshold. For the patient, understanding these incentives is the first step in moving from a passive billing unit to a Bayesian Decision Advocate. By recognizing the "Revenue Cascade," you can better evaluate whether a recommended "next step" is for your clinical benefit or the system's financial health.

Incentive Category	Central Agent	Economic Mechanism	Downstream Revenue Cascade	Supporting Citation
Direct Procedure Revenue	Primary Provider / Specialist	Relative Value Units (RVUs).  Compensation scales linearly with the number and complexity of procedures performed.	Initial high-sensitivity tests (e.g., MRI) justify subsequent billable biopsies or specialty consults.	Ginsburg & Berenson (2007). NEJM.
Defensive Medicine	Medical Practitioner	Legal risk mitigation.  Standard of Care (SOC) favors over-testing to avoid malpractice liability for missed diagnoses.	A "just-in-case" test triggers a chain of diagnostic interventions to rule out benign findings (noise).	Rothberg (2014). JAMA Internal Medicine.
Facility Fees	Hospital / Health System	Hospitals charge overhead fees for every use of high-capital equipment (CT, MRI, Surgical Suites).	Referrals are funneled to in-network imaging centers, keeping technical component revenue within the system.	Song, et al. (2014). NEJM.
Referral Leakage Control	Health System Admin	Bonuses or "shadow" incentives for keeping referrals "in-house" (vertical integration).	Patient is moved through a "closed loop" of specialists, ensuring every dollar of the cascade stays in the network.	Baker, et al. (2014). Health Affairs.
Administrative Compliance	Insurance Carriers	Standard Operating Procedures (SOPs).  Automated approval for tests that meet rigid, high-sensitivity criteria.	Predictable billing patterns allow insurers to manage reserves and administrative overhead with less manual review.	Clemens & Gottlieb (2014). American Economic Review.
Prescription / Device Pull-through	Specialists / Pharma	Diagnostic results (even false positives) create the SOP justification for long-term pharmaceutical or device use.	One scan leads to a "pre-disease" diagnosis, creating a lifetime value (LTV) patient for specific drug classes.	Welch, et al. (2011). Overdiagnosed.

High-Sensitivity "Signal" Specialties

Certain disciplines are particularly susceptible to the high-sensitivity trap. In these fields, the Standard of Care is more likely to default to the invasive confirmation of "noisy" or benign findings.

Specialty	High-Sensitivity "Gateway"	The Economic Result / Cascade
Dermatology	The Benign Blemish. Visual screening of atypical moles or minor skin irregularities.	High-volume biopsies followed by wide-excision or Mohs surgery for non-threatening findings.
Breast Surgery	The "Stage 0" Discovery. Identifying Ductal Carcinoma In Situ (DCIS) via mammography.	A positive screen triggers a multidisciplinary cascade of biopsies, oncology consults, and complex reconstructions.
Gastroenterology	The Routine Polyp. Identifying benign or slow-growing growths during colonoscopy.	Increased surveillance frequency (shorter return windows) and recurring surgical center facility fees.
Urology	The Elevated PSA. High-sensitivity blood markers for prostate health.	Ambiguous results justify invasive biopsies and high-margin robotic surgeries for low-risk conditions.
Endocrinology	The "Pre-Condition" Marker. Borderline lab results for thyroid or blood sugar levels.	Conversion of healthy individuals into lifetime pharmaceutical consumers requiring quarterly lab monitoring.
Orthopedics	The Asymptomatic Tear. Age-related wear identified on high-resolution MRIs.	Surgical "clean-out" procedures for findings which often do not correlate with the patient's actual pain.

The Decision Advocate’s Toolkit

The following table provides actionable strategies to move from a passive recipient of Sick Care to an active manager of your Health Care. These ideas help you manage employer-provided Sick Care "benefits" to help you achieve long-term healthy outcomes.

Action Category	Specific Strategy	Bayesian Rationale
Incentive Transparency	Declare Financial Exposure. Explicitly inform the provider of your high deductible or financial hardship at the start of the encounter.	Piercing the Veil. Nudging the provider to acknowledge your "skin in the game" breaks their clinical insulation. It encourages them to move from a default "Standard of Care" to a more discerning, high-specificity judgment.
Global Arbitrage	Medical Tourism. Seek common, high-cost elective procedures (orthopedic, bariatric, or dental) in Tier-1 international facilities.	Exiting the Local Bubble. This removes the patient from the US billing "Referral Trap" and administrative bloat. Prices are transparent, and the quality often matches or exceeds domestic standards for common surgeries.
Financial Structuring	Opt for High Deductible / HSA Plans. Choose plans requiring out-of-pocket spending for initial care.	Skin in the Game. Personal financial exposure acts as a cognitive filter, forcing a skeptical evaluation of "Routine" procedures.
Provider Selection	Engage Direct Primary Care (DPC). Pay a flat monthly fee to a physician who does not bill insurance companies.	Incentive Alignment. DPC doctors profit from your long-term healthspan and time-efficiency rather than procedural volume (RVUs).
Diagnostic Skepticism	Request the "30-Day Wait" Probability. Ask the doctor: "What is the probability this resolves itself if we do nothing for 30 days?"	Establishing the Base Rate. Many signals in the body are temporary "noise." This question forces the provider to acknowledge the body’s natural healing capacity.
Price Transparency	Cash-Pay for High-Value Imaging. Use independent centers for MRIs or CT scans instead of hospital-affiliated sites.	Breaking the Referral Trap. Hospitals use sensitive diagnostics to funnel patients into expensive surgical cascades. Paying cash at a third party decouples the data from the billing machine.
Logic Verification	The Second Opinion "Ghosting." Do not share the first doctor’s diagnosis until after the new exam.	Avoiding Confirmation Bias. This ensures the second data point is independent and not merely a "Standard of Care" rubber stamp of the previous finding.

Technical Notes

Math Notation

This Signal Detection Theory analysis describes a shift in the decision criterion β toward higher sensitivity, rather than an improvement in the system's underlying discriminability d'.

Signal Detection Theory and the Assumption of Normalcy

In Signal Detection Theory (SDT), the variability of diagnostic testing is categorized into four distinct outcomes: True Positive, False Positive (The "positives" relate to Sensitivity), True Negative, and False Negative (The "negatives" relate to Specificity). These outcomes are visualized through two overlapping probability distributions.

The first is the Noise Distribution, which represents data points not related to the condition. In the exam room, this represents the physiological "noise" of healthy individuals. The second is the Signal Distribution, which contains the information specific to the condition being tested.

Standard models often utilize Normal Distributions, or bell curves, to describe these areas. While the normal distribution provides a functional heuristic for understanding how a high-sensitivity machine operates, one must remain wary of the "Assumption of Normalcy."

Real-world medical data frequently exhibit fat tails or skewness. Fat tails imply that extreme outliers—data points far from the average—occur more often than a standard model predicts. Skewness indicates an asymmetrical distribution where data leans toward one side. In a Sick Care environment, these statistical deviations often expand the overlap where irrelevant "Noise" is mistaken for a diagnostic "Signal." This expansion creates more opportunities for the high-sensitivity machine to trigger billable interventions. This makes being a Bayesian Decision Advocate even more important.

Resources for the Curious

Arrow, Kenneth J. "Uncertainty and the Welfare Economics of Medical Care." The American Economic Review 53, no. 5 (1963): 941–73.

Attia, Peter, and Bill Gifford. Outlive: The Science and Art of Longevity. New York: Harmony Books, 2023.

Baker, Laurence C., M. Kate Bundorf, and Anne Royalty. "Vertical Integration: Hospital Ownership of Physician Practices Is Associated with Higher Prices and Spending." Health Affairs 33, no. 5 (2014): 756–63. https://doi.org/10.1377/hlthaff.2013.1279.

Buettner, Dan. The Blue Zones: Lessons for Living Longer from the People Who've Lived the Longest. Washington, D.C.: National Geographic, 2008.

Gelman, Andrew, and Robert Kass. "Statisticians: The Professionals of Uncertainty." Science 318, no. 5857 (2007): 1717–18.

Ginsburg, Paul B., and Robert A. Berenson. "Revising Relative Value Units — Strengthening the HCFA Process." New England Journal of Medicine 356, no. 12 (2007): 1201–3. https://doi.org/10.1056/NEJMp078017.

Hofmann, Bjørn, and H. Gilbert Welch. "Newer Is Not Necessarily Better: Overdiagnosis and Overtreatment." BMJ 358 (2017): j2973. https://doi.org/10.1136/bmj.j2973.

Hulett, Jeff. "De-Moral Hazarding: Beat Insurers at Their Own Game and Build Wealth in the Process," Personal Finance Reimagined, 2025, https://www.financerevamp.com/post/de-moral-hazarding.

Ioannidis, John P. A. "Why Most Published Research Findings Are False." PLoS Medicine 2, no. 8 (2005): e124. https://doi.org/10.1371/journal.pmed.0020124.

Kahneman, Daniel. Thinking, Fast and Slow. New York: Farrar, Straus and Giroux, 2011.

Kahneman, Daniel, and Amos Tversky. "Prospect Theory: An Analysis of Decision under Risk." Econometrica 47, no. 2 (1979): 263–91. https://doi.org/10.2307/1914185.

Lakdawalla, Darius, and Charles E. Phelps. "Health Technology Assessment with Risk Aversion in Health." National Bureau of Economic Research (NBER) Working Paper No. 26715 (2020). https://www.nber.org/papers/w26715.

Lin, Gary A., Kevin F. Erickson, and James D. Reschovsky. "Communicating with Patients about the Costs of Medical Care." Journal of the American Board of Family Medicine 26, no. 6 (2013): 761–73. https://doi.org/10.3122/jabfm.2013.06.130003.

McGrayne, Sharon Bertsch. The Theory That Would Not Die: How Bayes' Rule Cracked the Enigma Code, Hunted Down Russian Submarines, and Emerged Triumphant from Two Centuries of Controversy. New Haven: Yale University Press, 2011.

Pinker, Steven. Rationality: What It Is, Why It Seems Scarce, Why It Matters. New York: Viking, 2021.

Rothberg, Michael B. "The Staggering Cost of Defensive Medicine." JAMA Internal Medicine 174, no. 9 (2014): 1459–60. https://doi.org/10.1001/jamainternmed.2014.1347.

Schaeffer Center for Health Policy & Economics. "Generalized Risk-Adjusted Cost-Effectiveness (GRACE): A New Era of Health Care Value." University of Southern California, 2022.

Sowell, Thomas. A Conflict of Visions: Ideological Origins of Political Struggles. New York: William Morrow, 1987.

Taleb, Nassim Nicholas. Skin in the Game: Hidden Asymmetries in Daily Life. New York: Random House, 2018.

Welch, H. Gilbert, Lisa Schwartz, and Steven Woloshin. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston: Beacon Press, 2011.